vs
Ardmore Shipping Corp（ASC）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Ardmore Shipping Corp的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$81.2M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 15.7%，领先368.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -15.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -6.0%）
阿德莫尔航运是一家全球化海上运输企业，持有并运营中型成品油轮与化学品运输船队，可为全球能源、化工及贸易领域客户提供石油产品、特种化学品及其他散装液态货物的海运服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ASC vs RIGL — 直观对比
营收规模更大
ASC
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出36.7%
-15.5%
净利率更高
RIGL
高出368.3%
15.7%
两年增速更快
RIGL
近两年复合增速
-6.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $81.2M | $69.8M |
| 净利润 | $12.8M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 16.1% | 33.2% |
| 净利率 | 15.7% | 384.0% |
| 营收同比 | -15.5% | 21.2% |
| 净利润同比 | -47.0% | 1769.2% |
| 每股收益（稀释后） | $0.30 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASCRIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | $81.2M | $69.5M | ||
| Q2 25 | $72.0M | $101.7M | ||
| Q1 25 | $74.0M | $53.3M | ||
| Q4 24 | — | $57.6M | ||
| Q3 24 | $96.1M | $55.3M | ||
| Q2 24 | $121.3M | $36.8M | ||
| Q1 24 | $106.3M | $29.5M |
净利润ASCRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $12.8M | $27.9M | ||
| Q2 25 | $9.6M | $59.6M | ||
| Q1 25 | $6.3M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $24.1M | $12.4M | ||
| Q2 24 | $62.7M | $-1.0M | ||
| Q1 24 | $39.2M | $-8.2M |
毛利率ASCRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率ASCRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | 16.1% | 40.9% | ||
| Q2 25 | 13.5% | 60.1% | ||
| Q1 25 | 8.6% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | 25.4% | 25.4% | ||
| Q2 24 | 51.3% | 1.2% | ||
| Q1 24 | 37.2% | -23.6% |
净利率ASCRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 15.7% | 40.2% | ||
| Q2 25 | 13.3% | 58.6% | ||
| Q1 25 | 8.5% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 25.1% | 22.5% | ||
| Q2 24 | 51.7% | -2.8% | ||
| Q1 24 | 36.9% | -27.9% |
每股收益（稀释后）ASCRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $0.30 | $1.46 | ||
| Q2 25 | $0.22 | $3.28 | ||
| Q1 25 | $0.14 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | $0.55 | $0.70 | ||
| Q2 24 | $1.47 | $-0.06 | ||
| Q1 24 | $0.92 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | $116.1M | $52.5M |
| 股东权益账面价值 | $628.2M | $391.5M |
| 总资产 | $799.8M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.18× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ASCRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务ASCRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | $116.1M | $60.0M | ||
| Q2 25 | $25.0M | $60.0M | ||
| Q1 25 | $20.5M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | $22.5M | $60.0M | ||
| Q2 24 | $44.2M | $60.0M | ||
| Q1 24 | $23.1M | $60.0M |
股东权益ASCRIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | $628.2M | $117.6M | ||
| Q2 25 | $618.3M | $81.9M | ||
| Q1 25 | $610.7M | $18.6M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $627.0M | $-14.6M | ||
| Q2 24 | $617.7M | $-29.9M | ||
| Q1 24 | $567.9M | $-31.7M |
总资产ASCRIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | $799.8M | $242.5M | ||
| Q2 25 | $703.8M | $206.7M | ||
| Q1 25 | $690.4M | $176.0M | ||
| Q4 24 | — | $164.0M | ||
| Q3 24 | $722.8M | $139.4M | ||
| Q2 24 | $742.0M | $128.4M | ||
| Q1 24 | $704.1M | $126.5M |
负债/权益比ASCRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | 0.18× | 0.51× | ||
| Q2 25 | 0.04× | 0.73× | ||
| Q1 25 | 0.03× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.40× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASCRIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $17.9M | $24.0M | ||
| Q2 25 | $11.2M | $30.5M | ||
| Q1 25 | $26.3M | $-893.0K | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | $39.9M | $21.7M | ||
| Q2 24 | $48.4M | $302.0K | ||
| Q1 24 | $49.2M | $-5.0M |
现金转化率ASCRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.40× | 0.86× | ||
| Q2 25 | 1.17× | 0.51× | ||
| Q1 25 | 4.20× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.65× | 1.75× | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.25× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
